DPI Formulation Development And Manufacturing

Building on particle engineering expertise to optimize respiratory drug delivery and bring advanced therapeutics to market

The respiratory system provides an attractive drug absorption target for both local and systemic disease states and is increasingly utilized for the delivery of both small molecules and biotherapeutics.

Our core particle engineering expertise through milling and/or spray drying is complemented with extensive formulation and process development, specialized relevant characterization tools that allow mechanistic understanding, and encapsulation capabilities to provide integrated respiratory product development from concept through the clinic and commercialization.

Lonza has extensive experience in formulation development and manufacturing of respiratory drug-delivery products from proof of concept (POC) to manufacturing of dry-powder inhaled (DPI) formulations.